LVZPF
Price
$3.43
Change
-$0.09 (-2.56%)
Updated
Dec 16 closing price
UPC
Price
$0.68
Change
-$0.01 (-1.45%)
Updated
Dec 18 closing price
Ad is loading...

LVZPF vs UPC

Header iconLVZPF vs UPC Comparison
Open Charts LVZPF vs UPCBanner chart's image
Livzon Pharmaceutical Group
Price$3.43
Change-$0.09 (-2.56%)
Volume$1.19K
CapitalizationN/A
Universe Pharmaceuticals
Price$0.68
Change-$0.01 (-1.45%)
Volume$501.69K
CapitalizationN/A
LVZPF vs UPC Comparison Chart
Loading...
LVZPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UPC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LVZPF vs. UPC commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LVZPF is a Hold and UPC is a Hold.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (LVZPF: $3.43 vs. UPC: $0.68)
Brand notoriety: LVZPF and UPC are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: LVZPF: 13% vs. UPC: 21%
Market capitalization -- LVZPF: $3.46B vs. UPC: $7.98M
LVZPF [@Pharmaceuticals: Other] is valued at $3.46B. UPC’s [@Pharmaceuticals: Other] market capitalization is $7.98M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.53B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LVZPF’s FA Score shows that 1 FA rating(s) are green whileUPC’s FA Score has 0 green FA rating(s).

  • LVZPF’s FA Score: 1 green, 4 red.
  • UPC’s FA Score: 0 green, 5 red.
According to our system of comparison, UPC is a better buy in the long-term than LVZPF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LVZPF’s TA Score shows that 0 TA indicator(s) are bullish while UPC’s TA Score has 3 bullish TA indicator(s).

  • LVZPF’s TA Score: 0 bullish, 1 bearish.
  • UPC’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, LVZPF is a better buy in the short-term than UPC.

Price Growth

LVZPF (@Pharmaceuticals: Other) experienced а -2.56% price change this week, while UPC (@Pharmaceuticals: Other) price change was -36.07% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.75%. For the same industry, the average monthly price growth was +1.64%, and the average quarterly price growth was -9.20%.

Reported Earning Dates

UPC is expected to report earnings on Feb 10, 2023.

Industries' Descriptions

@Pharmaceuticals: Other (+0.75% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LVZPF($3.46B) has a higher market cap than UPC($7.99M). LVZPF has higher P/E ratio than UPC: LVZPF (12.87) vs UPC (3.00). LVZPF YTD gains are higher at: 10.289 vs. UPC (-97.731). LVZPF has higher annual earnings (EBITDA): 361M vs. UPC (-7.29M). LVZPF has more cash in the bank: 1.33B vs. UPC (5.71M). UPC has less debt than LVZPF: UPC (3.94M) vs LVZPF (556M). LVZPF has higher revenues than UPC: LVZPF (1.74B) vs UPC (40.1M).
LVZPFUPCLVZPF / UPC
Capitalization3.46B7.99M43,381%
EBITDA361M-7.29M-4,953%
Gain YTD10.289-97.731-11%
P/E Ratio12.873.00429%
Revenue1.74B40.1M4,349%
Total Cash1.33B5.71M23,271%
Total Debt556M3.94M14,126%
FUNDAMENTALS RATINGS
LVZPF: Fundamental Ratings
LVZPF
OUTLOOK RATING
1..100
99
VALUATION
overvalued / fair valued / undervalued
1..100
2
Undervalued
PROFIT vs RISK RATING
1..100
94
SMR RATING
1..100
56
PRICE GROWTH RATING
1..100
53
P/E GROWTH RATING
1..100
53
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LVZPFUPC
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
20%
Bullish Trend 7 days ago
87%
Momentum
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
N/A
Bullish Trend 16 days ago
84%
Declines
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
LVZPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UPC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VRAX2.370.67
+39.41%
Virax Biolabs Group Limited
VERA43.91-0.05
-0.11%
Vera Therapeutics
KMX81.42-1.70
-2.05%
CarMax
FUNC34.16-1.37
-3.86%
First United Corp
TRDA17.10-1.35
-7.32%
Entrada Therapeutics

LVZPF and

Correlation & Price change

A.I.dvisor indicates that over the last year, LVZPF has been loosely correlated with LIFD. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if LVZPF jumps, then LIFD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LVZPF
1D Price
Change %
LVZPF100%
N/A
LIFD - LVZPF
34%
Loosely correlated
N/A
UPC - LVZPF
8%
Poorly correlated
+1.40%
CLCFF - LVZPF
6%
Poorly correlated
-2.53%
AAWH - LVZPF
2%
Poorly correlated
+2.95%
VRNOF - LVZPF
2%
Poorly correlated
+6.56%
More

UPC and

Correlation & Price change

A.I.dvisor tells us that UPC and DRRX have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that UPC and DRRX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UPC
1D Price
Change %
UPC100%
-0.79%
DRRX - UPC
27%
Poorly correlated
-6.16%
TXMD - UPC
22%
Poorly correlated
-3.51%
PROC - UPC
14%
Poorly correlated
-18.70%
CRON - UPC
13%
Poorly correlated
-3.08%
ASRT - UPC
13%
Poorly correlated
-6.32%
More